Europe Empty Capsules Market

Europe Empty Capsules Market Size 

The Europe Empty Capsules Market was valued at USD 372.77 million in 2024. The Europe Empty Capsules Market is expected to have 6.4% CAGR from 2025 to 2033 and be worth USD 651.50 million by 2033 from USD 396.63 million in 2025.  

Gelatin is a protein produced by plants and animals that are used to make empty capsules. Prescription and over-the-counter medications, nutrient supplements, and herbal products all employ this dosage form.

The rising prevalence of non-communicable diseases such as cancer, diabetes, heart disease, and lung disorders has increased nutraceuticals. As most nutraceuticals are sold in capsule form, this is a good sign of market expansion. In addition, the empty capsules are useful for masking the taste of cardiovascular medications, which significantly favored the market in the European region. As a result, the post-pandemic rise of the empty capsule market is expected to accelerate. Furthermore, the expanding number of medications marketed as capsule formulations and the rising prevalence of disorders for which capsule-based formulations are principal treatments are driving demand for empty capsules in the pharmaceutical business.

However, factors such as ethical concerns, price variations in gelatin materials, and tight regulations in the pharmaceutical business are expected to negatively impact the European empty capsules market during the forecast period. Furthermore, the growth of the European empty capsule market is further expected to be hampered by a dearth of trained laboratory workers and the government’s strict rules and regulations requiring only high-quality medicines to be approved. Additionally, a lack of awareness about how to use these goods is slowing the growth of the empty capsules market.

REGIONAL ANALYSIS

Geographically, the European market is the second-largest regional market for the global empty capsules market.

The market’s demand for empty capsules is expanding as a result of their easy absorption rate. In addition, an ever-increasing patient pool is also a driving force in the market. Germany and the United Kingdom are at the top of the market, with increased backing from commercial and state institutions.The largest product segment is gelatin capsules, whereas non-gelatin capsules are expected to grow at the fastest rate, with a high CAGR, due to a growing desire for vegetable origin capsules. For the empty capsules market, the pharmaceutical industry is the major end-user category. Empty capsules are in more demand due to the growing emphasis on superior pharmaceutical items and generics. Qualicaps Europe S.A.U expanded its presence in South Asia in February 2024. The company has capsule manufacturing professionals in EMEA and South Asia and two production sites in Europe. The high prevalence of cardiovascular illness in the United Kingdom pushes up demand for effective cardiovascular therapy medications, promoting the market’s growth.

KEY MARKET PLAYERS

A few noteworthy companies operating in the European empty capsules market profiled in this report are Capsugel, ACG Worldwide, Suheung Co Ltd., Bright Pharmacaps Inc., Capscanada Corporation, Medi-Caps Ltd., Qualicaps, Roxlor, LLC, Snail Pharma Industry Co.Ltd, and Sunil Healthcare Limited.

MARKET SEGMENTATION

This research report on the European empty capsules market has been segmented and sub-segmented into the following categories.

By Product

• Gelatin Capsules
• Non-Gelatin Capsules

By Therapeutic Application

• Antibiotic And Antibacterial Drugs
• Vitamins And Dietary Supplements
• Antacid And Antiflatulent Preparations
• Antianemic Preparations
• Anti-Inflammatory Drugs
• Cardiovascular Therapy Drugs
• Cough And Cold Preparations
• Other Therapeutic Application

By End User

• Pharmaceutical Industry
• Nutraceutical Industry
• Cosmetics Industry
• Research Laboratories

By Country 

• UK
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Turkey
• Czech Republic
• Rest of Europe